Atara Biotherapeutics, Inc. (ATRA)
NASDAQ·Healthcare·Biotechnology
$9.45
-4.45%
Mkt Cap $40.81M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (7 analysts)
$13.00
Range $13.00 – $13.00
Implied Upside
+37.6%
Consensus $13.00 vs current $9.45
NASDAQ·Healthcare·Biotechnology
$9.45
-4.45%
Mkt Cap $40.81M
Buy
1
Hold
1
Sell
0
Price Target (7 analysts)
$13.00
Range $13.00 – $13.00
+37.6%
Consensus $13.00 vs current $9.45